Patents by Inventor Saba Farooq

Saba Farooq has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210361733
    Abstract: Due to the SARS-CoV-2 pandemic, the development and screening of novel antiviral agents are urgently required. Herein, we developed herbal extracts with promising antiviral activity against SARS-CoV-2. Antiviral effects of Mentha piperita, and Flos chrysanthemi extracts alone, in combination and their fractions were found to decrease viral load. To determine which step of the virus is inhibited by the treatment, the extracts were administered at different time points of treatment, namely prophylactic (Full-time), pre-adsorption (Entry), and post adsorption (Post-entry). Most of the fractions, exhibited high efficacy upon prophylactic administration. The viral load was lower in prophylactic-treated cells than in non-treated cells. Administration of combinations, following 2:1 molar ratio of Mentha piperita, and Flos chrysanthemi significantly reduced the viral load by increasing the Cq values.
    Type: Application
    Filed: August 6, 2021
    Publication date: November 25, 2021
    Inventors: Atta-ur- Rahman, Muhammad Iqbal Choudhary, Saba Farooq, Atia-tul- Wahab
  • Patent number: 9387186
    Abstract: Two thiourea derivatives N-(3-chlorophenyl)-N?-(3,4-difluorophenyl)thiourea and N-(3-chlorophenyl)-N-(3-methoxyphenyl)-thiourea are reported as treatment of multidrug resistance infections from Staphylococcus aureus.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: July 12, 2016
    Inventors: Muhammad Iqbal Choudhary, Saba Farooq, Khalid M. Khan, Farzana Naz, Atia-tul Wahab, Atta-ur Rahman
  • Publication number: 20150335594
    Abstract: Two thiourea derivatives N-(3-chlorophenyl)-N?-(3,4-difluorophenyl) thiourea and N-(3-chlorophenyl)-N-(3-methoxyphenyl)-thiourea are reported as treatment of multidrug resistance infections from Staphylococcus aureus.
    Type: Application
    Filed: May 22, 2014
    Publication date: November 26, 2015
    Inventors: Muhammad Iqbal Choudhary, Saba Farooq, Khalid M. Khan, Farzana Naz, Atia-tul Wahab, Atta-ur Rahman
  • Patent number: 8889733
    Abstract: Artonin I is reported to treat multi-drug resistant Staphlococcus infections.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: November 18, 2014
    Inventors: Muhammad Iqbal Choudhary, Saba Farooq, Atia-tul Wahab, Christian D. A. Fozing, Atta-ur Rahman
  • Publication number: 20140200189
    Abstract: Artonin I is reported to treat multi-drug resistant Staphlococcus infections.
    Type: Application
    Filed: January 14, 2013
    Publication date: July 17, 2014
    Inventors: Muhammad Iqbal Choudhary, Saba Farooq, Atia-tul-Wahab, Christian D.A. Fozing